NEW YORK (GenomeWeb News) – A new Science Translational Medicine study suggests high-throughput sequencing is effective for finding post-treatment leukemia cells that can lead to patient relapse.

Researchers from Fred Hutchinson Cancer Research Center, the University of Washington, and elsewhere used high-throughput sequencing to test matched pre- and post-chemotherapy samples from 43 individuals with T-lineage acute lymphoblastic leukemia, looking at how well their high-throughput sequencing method detected lingering leukemia cells compared with flow cytometry.

To read the full story....

Register for Free.

Already have a GenomeWeb or 360Dx account?
Login Now.

A phylogenetic analysis indicates two venomous Australian spiders are more closely related than thought, the International Business Times reports.

Technology Review reports that 2017 was the year of consumer genetic testing and that it could spur new analysis companies.

In Science this week: CRISPR-based approach for recording cellular events, and more.

A new company says it will analyze customers' genes to find them a suitable date, though Smithsonian magazine says the science behind it might be shaky.

Feb
21
Sponsored by
Oracle Health Sciences

This webinar will cover best practices for integrating data from multiple clinical and genomic sources for clinical decision support.